MiR-122 elevation has been found to aggravate insulin resistance in hepatocytes by targeting insulin-like growth factor 1 receptor (Igf-1r), indicating that it has a possible contribution to the progression of atherosclerosis in T2D [35]. Here, IGF1R is linked to atherosclerosis.